BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35964554)

  • 1. Prolonged visual evoked potential latency predicts longitudinal worsening of fatigue in people with multiple sclerosis.
    Covey TJ; Golan D; Doniger GM; Sergott R; Zarif M; Bumstead B; Buhse M; Kaczmarek O; Mebrahtu S; Bergmann C; Wilken J; Gudesblatt M
    Mult Scler Relat Disord; 2022 Nov; 67():104073. PubMed ID: 35964554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of the relationship between visual evoked potentials and cognitive performance in multiple sclerosis.
    Covey TJ; Golan D; Doniger GM; Sergott R; Zarif M; Bumstead B; Buhse M; Kaczmarek O; Mebrahtu S; Bergmann C; Wilken J; Gudesblatt M
    Clin Neurophysiol; 2022 May; 137():66-74. PubMed ID: 35279530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between cognitive impairment, cognitive fatigue, and visual evoked potential latency in people with multiple sclerosis.
    Covey TJ; Golan D; Doniger GM; Sergott R; Zarif M; Bumstead B; Buhse M; Kaczmarek O; Mebrahtu S; Bergmann C; Wilken J; Gudesblatt M
    Mult Scler Relat Disord; 2022 Jan; 57():103349. PubMed ID: 35158458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual differences in visual evoked potential latency are associated with variance in brain tissue volume in people with multiple sclerosis: An analysis of brain function-structure correlates.
    Covey TJ; Golan D; Zarif M; Bumstead B; Buhse M; Kaczmarek O; Sergott R; Wilken J; Sima DM; Van Hecke W; Gudesblatt M
    Mult Scler Relat Disord; 2022 Dec; 68():104116. PubMed ID: 36041331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual evoked potential latency predicts cognitive function in people with multiple sclerosis.
    Covey TJ; Golan D; Doniger GM; Sergott R; Zarif M; Srinivasan J; Bumstead B; Wilken J; Buhse M; Mebrahtu S; Gudesblatt M
    J Neurol; 2021 Nov; 268(11):4311-4320. PubMed ID: 33870445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis.
    Covey TJ; Golan D; Sergott R; Wilken J; Zarif M; Bumstead B; Buhse M; Kaczmarek O; Doniger GM; Penner IK; Hancock LM; Bogaardt H; Barrera MA; Morrow SA; Galetta S; Gudesblatt M
    J Neurol; 2024 Feb; 271(2):658-673. PubMed ID: 38091086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of visual and auditory evoked potentials in multiple sclerosis patients with and without fatigue.
    Pokryszko-Dragan A; Bilinska M; Gruszka E; Kusinska E; Podemski R
    Neurol Sci; 2015 Feb; 36(2):235-42. PubMed ID: 25240278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and fatigue in patients with multiple sclerosis.
    Greeke EE; Chua AS; Healy BC; Rintell DJ; Chitnis T; Glanz BI
    J Neurol Sci; 2017 Sep; 380():236-241. PubMed ID: 28870578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?
    Téllez N; Río J; Tintoré M; Nos C; Galán I; Montalban X
    Mult Scler; 2005 Apr; 11(2):198-202. PubMed ID: 15794395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the measurement properties of the PROMIS Fatigue (MS) 8a against legacy fatigue questionnaires.
    Kamudoni P; Johns J; Cook KF; Salem R; Salek S; Raab J; Middleton R; Henke C; Amtmann D
    Mult Scler Relat Disord; 2022 Oct; 66():104048. PubMed ID: 35905689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.
    Niklas A; Sebraoui H; Hess E; Wagner A; Then Bergh F
    Mult Scler; 2009 Jan; 15(1):68-74. PubMed ID: 18701569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis.
    Piedrabuena R; Bittar M
    Mult Scler Relat Disord; 2022 Jan; 57():103420. PubMed ID: 34906813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of fatigue and its explicative variables among people with multiple sclerosis.
    Royer N; Duboeuf M; Camdessanché JP; Millet GY
    NeuroRehabilitation; 2022; 51(3):509-517. PubMed ID: 36057800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally important difference of the fatigue severity scale and modified fatigue impact scale in people with multiple sclerosis.
    Rooney S; McFadyen DA; Wood DL; Moffat DF; Paul PL
    Mult Scler Relat Disord; 2019 Oct; 35():158-163. PubMed ID: 31400557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is chronic fatigue the symptom of venous insufficiency associated with multiple sclerosis? A longitudinal pilot study.
    Malagoni AM; Galeotti R; Menegatti E; Manfredini F; Basaglia N; Salvi F; Zamboni P
    Int Angiol; 2010 Apr; 29(2):176-82. PubMed ID: 20351673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the relation between reserve and fatigue in multiple sclerosis.
    Tranfa M; Iuzzolino VV; Perrella P; Carotenuto A; Pontillo G; Moccia M; Cocozza S; Elefante A; Lanzillo R; Brunetti A; Brescia Morra V; Petracca M
    Mult Scler Relat Disord; 2023 Aug; 76():104842. PubMed ID: 37392716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of Korean version of Modified Fatigue Impact Scale (MFIS) for Korean patients with multiple sclerosis.
    Chung YH; Jeong A; Kim BJ; Park K; Min JH
    Mult Scler Relat Disord; 2022 Jun; 62():103811. PubMed ID: 35462169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
    Kiiski HS; Ní Riada S; Lalor EC; Gonçalves NR; Nolan H; Whelan R; Lonergan R; Kelly S; O'Brien MC; Kinsella K; Bramham J; Burke T; Ó Donnchadha S; Hutchinson M; Tubridy N; Reilly RB
    PLoS One; 2016; 11(1):e0146084. PubMed ID: 26726800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysing the relationship between polysomnographic measures of sleep with measures of physical and cognitive fatigue in people with multiple sclerosis.
    Chinnadurai SA; Gandhirajan D; Pamidimukala V; Kesavamurthy B; Venkatesan SA
    Mult Scler Relat Disord; 2018 Aug; 24():32-37. PubMed ID: 29883851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness and clinically meaningful changes for the Persian versions of the multiple sclerosis walking scale-12 and the modified fatigue impact scale following balance and gait rehabilitation in people with multiple sclerosis.
    Monjezi S; Molhemi F; Shaterzadeh Yazdi MJ; Salehi R; Mehravar M; Kashipazha D
    Physiother Theory Pract; 2022 Mar; 38(3):464-470. PubMed ID: 32431220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.